The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

Mosquitoes are highly visual hunters when it comes to finding a human to bite. This means movement and dark clothing colors ...

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

Highlighting the pivotal role of VHSNCs in addressing public health concerns, the minister said that the committees would ...

The diseases include dengue, chikungunya, zika and yellow fever among others. India experiences a large number of deaths due ...

However, researchers found the reverse was also true, with psychotic episodes nearly doubling the chances a child would be ...